Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Prockop

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Haematologica|December 3, 2011
Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literatureDavid J Araten, Rosario Notaro, Howard T Thaler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2020
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host DiseaseJoanne Kurtzberg, Hisham Abdel-Azim, Paul Carpenter, et al.
Cytotherapy|July 6, 2024
International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges facedAshish O Gupta, Melissa Azul, Senthil Velan Bhoopalan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2011
Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT)Joanne F Chou, Nancy A Kernan, Susan Prockop, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2007
Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignanciesTrudy N Small, James W Young, Hugo Castro-Malaspina, et al.
Cytotherapy|February 13, 2024
Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patientsMadhavi Lakkaraja, Audrey Mauguen, Farid Boulad, et al.
The Journal of Allergy and Clinical Immunology. Global|April 21, 2026
International clinical consensus on leukocyte adhesion deficiency-I: Modified Delphi analysisJennifer Heimall, Luis Ignacio González-Granado, Claire Booth, et al.
Cytotherapy|March 20, 2023
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantMoises Garcia-Rosa, Allistair Abraham, Alice Bertaina, et al.
Cell Reports|January 15, 2025
The Golgi complex governs natural killer cell lytic granule positioning to promote directionality in cytotoxicityLuis A Pedroza, Frederique van den Haak, Alexander Frumovitz, et al.
The Journal of Allergy and Clinical Immunology|June 27, 2023
Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutationsBinni Kunvarjee, Alan Bidgoli, Rebecca Pellett Madan, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Haematologica|December 3, 2011
Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literatureDavid J Araten, Rosario Notaro, Howard T Thaler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2020
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host DiseaseJoanne Kurtzberg, Hisham Abdel-Azim, Paul Carpenter, et al.
Cytotherapy|July 6, 2024
International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges facedAshish O Gupta, Melissa Azul, Senthil Velan Bhoopalan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2011
Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT)Joanne F Chou, Nancy A Kernan, Susan Prockop, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2007
Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignanciesTrudy N Small, James W Young, Hugo Castro-Malaspina, et al.
Cytotherapy|February 13, 2024
Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patientsMadhavi Lakkaraja, Audrey Mauguen, Farid Boulad, et al.
The Journal of Allergy and Clinical Immunology. Global|April 21, 2026
International clinical consensus on leukocyte adhesion deficiency-I: Modified Delphi analysisJennifer Heimall, Luis Ignacio González-Granado, Claire Booth, et al.
Cytotherapy|March 20, 2023
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantMoises Garcia-Rosa, Allistair Abraham, Alice Bertaina, et al.
Cell Reports|January 15, 2025
The Golgi complex governs natural killer cell lytic granule positioning to promote directionality in cytotoxicityLuis A Pedroza, Frederique van den Haak, Alexander Frumovitz, et al.
The Journal of Allergy and Clinical Immunology|June 27, 2023
Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutationsBinni Kunvarjee, Alan Bidgoli, Rebecca Pellett Madan, et al.
Pageof 7